Back to News
nNovember 14, 2022

Hear from our CEO Andrew Simpson how HeartSciences is working to transform the ECG into a far more effective referral tool

"Skip to content\nHome\nProducts\nClinical\nNews\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nHear from our CEO Andrew Simpson how HeartSciences is working to transform the ECG into a far more effective referral tool\nNovember 14, 2022\n\nWhen it comes to the AI ECG, we’re at the cutting edge of commercialization. Hear from our CEO Andrew Simpson how HeartSciences is working to transform the ECG into a far more effective referral tool\n\nContacts\nMEDIA RELATIONS\n\nGene Gephart\nDirector of Marketing\n+1-682-244-2578 (US)\n\ngene.gephart@heartsciences.com\nINVESTOR CONTACT\n\nMark Komonoski – Partner\nIntegrous Communications\nDirect: 877-255-8483\n\ninvestorrelations@heartsciences.com\nwww.integcom.us\n